Who founded Spiral Therapeutics?

Spiral Therapeutics was founded by Hugo Peris in 2016.

Who are Spiral Therapeutics's investors?

Spiral Therapeutics's investors include Catalio Capital Management, Alta Partners.

How much funding has Spiral Therapeutics raised?

Spiral Therapeutics has disclosed $46.5M raised across 3 rounds.

Where is Spiral Therapeutics headquartered?

Spiral Therapeutics is headquartered in South San Francisco, US.

Spiral Therapeutics

South San Francisco, US · Founded 2016 · Delaware corporation · 2 known investors

Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform. Its lead program, SPT-2101, is a sustained-release dexamethasone formulation for treating Ménière's disease.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Spiral Therapeutics was founded in 2016 by Hugo Peris.

Hugo PerisFounder & CEO

Eugene de JuanNamed on SEC filing

Lawrence FritzNamed on SEC filing

Board

WARREN THALERBoard director

JEAN-FREDERIC PAULSENBoard director

Guy NohraBoard directorInvestor at Alta Partners

ANTHONY ADAMISBoard director

FREDERIC GUERARDBoard director

Guy Jean Savoir GarciaBoard director

DIAMANTIS XYLASBoard director

ANGELA MACFARLANEBoard director

Investors · 2

Catalio Capital Management✓ verifiedNew York

Alta PartnersreportedJackson · $1M – $12Mvia Guy Nohra · board

Reported raises · per SEC filings

Form D private placements

$46.5M disclosed across 3 rounds · 2018–2025

▶$27.1MraisedApr 2026 · 34 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

WARREN THALERDirector
EUGENE DE JUANExecutive Officer, Director
ANTHONY ADAMISDirector
FREDERIC GUERARDDirector
JEAN-FREDERIC PAULSENDirector
GUY JEAN SAVOIR GARCIADirector
HUGO PERISExecutive Officer, Director
DIAMANTIS XYLASDirector
ANGELA MACFARLANEDirector

Offering amount: $27.1M
Amount sold: $27.1M
First sale: Sep 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$10.9MraisedFeb 2023 · 48 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

EUGENE DE JUANDirector
GUY P. NOHRADirector
ANGELA MACFARLANEDirector
GUY JEAN SAVOIR GARCIADirector
ANTHONY ADAMISDirector
HUGO PERISExecutive Officer, Director
DIAMANTIS XYLASDirector

Offering amount: $10.9M
Amount sold: $10.9M
First sale: Oct 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$8.5MraisedDec 2018 · 38 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Eugene de JuanDirector
Guy Jean Savoir GarciaDirector
Hugo PerisExecutive Officer, Director
Guy NohraDirector
Lawrence FritzDirector

Offering amount: $12.9M
Amount sold: $8.5M
First sale: Dec 2018
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Spiral Therapeutics do?: Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform. Its lead program, SPT-2101, is a sustained-release dexamethasone formulation for treating Ménière's disease.
Who founded Spiral Therapeutics?: Spiral Therapeutics was founded by Hugo Peris in 2016.
Who are Spiral Therapeutics's investors?: Spiral Therapeutics's investors include Catalio Capital Management, Alta Partners.
How much funding has Spiral Therapeutics raised?: Spiral Therapeutics has disclosed $46.5M raised across 3 rounds.
Where is Spiral Therapeutics headquartered?: Spiral Therapeutics is headquartered in South San Francisco, US.